The longevity and budgetary impact of the Australian Pharmaceutical Benefits Scheme

Presented by ANU College of Business & Economics

In his presentation, Frank will assess the effect of long-run changes in the drugs provided by the PBS on mortality and hospital utilisation in Australia. He will estimate that if the number of PBS drugs had not increased between 1996 and 2013, the number of years of life lost before age 85 in 2019 would have been 21.2 per cent higher than it actually was. Furthermore, he will demonstrate that the 1996-2013 increase in the number of PBS drugs reduced the number of years of life lost before age 85 in 2019 by 359,026.

Frank will show that if the number of PBS drugs had not increased between 1994 and 2011, the number of hospital days in 2019 would have been 10.6 per cent higher than it actually was, and that the 1994-2011 increase in the number of PBS drugs reduced the number of hospital days in 2019 by A$2.48 million.

About the presenter

Professor Frank Lichtenberg

 

 

Date and Times

Location

Room: Manning Clarke Hall, Cultural Centre (ANU Building 153), Kambri, University Avenue

Speakers

Contact